Atlas Trials

Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder

Clinical trial NCT02350309 · COMPLETED

Trial details

NCT number
NCT02350309
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Insomnia Disorder
Start date
2014-12-13
Primary completion
2015-04-21
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.